HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bo Huang Selected Research

IGA Glomerulonephritis (IGA Nephropathy)

10/2022The level of urinary C4d is associated with disease progression in IgA nephropathy with glomerular crescentic lesions: a cohort study.
1/2021Role of Human Mesangial-Tubular Crosstalk in Secretory IgA-Induced IgA Nephropathy.
12/2020The TLR4-MyD88-NF-κB pathway is involved in sIgA-mediated IgA nephropathy.
2/2018Differential expression of urinary exosomal microRNAs in IgA nephropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bo Huang Research Topics

Disease

221Neoplasms (Cancer)
05/2024 - 08/2002
39Inflammation (Inflammations)
12/2023 - 11/2008
35Neoplasm Metastasis (Metastasis)
04/2024 - 07/2007
22Infections
03/2024 - 05/2007
20Carcinogenesis
03/2024 - 05/2007
15Breast Neoplasms (Breast Cancer)
01/2023 - 02/2011
15Nasopharyngeal Carcinoma
01/2022 - 03/2005
14Lung Neoplasms (Lung Cancer)
05/2024 - 01/2012
14Fibrosis (Cirrhosis)
03/2024 - 12/2013
14Wounds and Injuries (Trauma)
03/2024 - 06/2012
13Carcinoma (Carcinomatosis)
04/2024 - 08/2002
13COVID-19
01/2024 - 01/2020
12Colorectal Neoplasms (Colorectal Cancer)
04/2024 - 07/2010
12Melanoma (Melanoma, Malignant)
01/2022 - 08/2008
11Stomach Neoplasms (Stomach Cancer)
01/2024 - 06/2013
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2024 - 01/2011
10Adenocarcinoma of Lung
04/2024 - 01/2015
10Insulin Resistance
01/2023 - 04/2011
9BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
03/2024 - 01/2008
9Intervertebral Disc Degeneration
11/2023 - 12/2011
8Disease Progression
04/2024 - 07/2010
8Pathologic Processes
03/2024 - 01/2011
8Renal Cell Carcinoma (Grawitz Tumor)
02/2024 - 02/2011
8Body Weight (Weight, Body)
02/2024 - 02/2015
8Hypoxia (Hypoxemia)
12/2023 - 02/2014
8Atrophy
11/2023 - 01/2009
8Hepatocellular Carcinoma (Hepatoma)
01/2023 - 01/2003
8Sepsis (Septicemia)
01/2023 - 02/2013
7Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2021 - 07/2013
7Malaria
01/2021 - 07/2013
7Hypertrophy
07/2019 - 02/2013
6Hemorrhage
11/2023 - 01/2017
6Pain (Aches)
01/2023 - 10/2013
6Fatigue
05/2021 - 02/2015
5Colonic Neoplasms (Colon Cancer)
05/2024 - 01/2010
5Lymphatic Metastasis
01/2024 - 01/2013
5Neurodegenerative Diseases (Neurodegenerative Disease)
12/2023 - 11/2012
5Experimental Melanoma
11/2023 - 08/2008
5Prostatic Neoplasms (Prostate Cancer)
07/2023 - 12/2015
5Pancreatic Neoplasms (Pancreatic Cancer)
11/2022 - 01/2017
5Pneumonia (Pneumonitis)
10/2022 - 01/2016
5Lung Injury
10/2022 - 10/2008
5Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
12/2020 - 11/2012
4Type 2 Diabetes Mellitus (MODY)
01/2024 - 07/2010

Drug/Important Bio-Agent (IBA)

84Proteins (Proteins, Gene)FDA Link
04/2024 - 06/2005
29Biomarkers (Surrogate Marker)IBA
04/2024 - 06/2011
25MicroRNAs (MicroRNA)IBA
06/2023 - 01/2010
22Messenger RNA (mRNA)IBA
03/2024 - 10/2008
16Peptides (Polypeptides)IBA
01/2024 - 01/2002
14AntigensIBA
11/2019 - 01/2002
13Small Interfering RNA (siRNA)IBA
04/2024 - 06/2005
13Glucose (Dextrose)FDA LinkGeneric
02/2024 - 09/2011
13RNA (Ribonucleic Acid)IBA
01/2024 - 05/2010
12CytokinesIBA
01/2024 - 09/2010
12LigandsIBA
11/2023 - 02/2008
11DNA (Deoxyribonucleic Acid)IBA
01/2023 - 05/2010
10Circular RNAIBA
01/2024 - 09/2021
10Interleukin-6 (Interleukin 6)IBA
12/2023 - 06/2005
10Long Noncoding RNAIBA
10/2023 - 01/2017
10Therapeutic UsesIBA
01/2023 - 09/2003
9Reactive Oxygen Species (Oxygen Radicals)IBA
12/2023 - 01/2015
9Interleukin-2 (IL2)IBA
01/2023 - 06/2008
9VaccinesIBA
03/2022 - 02/2015
8Anti-Bacterial Agents (Antibiotics)IBA
03/2024 - 05/2007
8CollagenIBA
01/2024 - 12/2011
8avelumabIBA
01/2023 - 01/2019
7RNA-Binding Proteins (RNA-Binding Protein)IBA
02/2024 - 01/2010
7Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
12/2023 - 01/2018
7EnzymesIBA
12/2023 - 06/2012
7Transcription Factors (Transcription Factor)IBA
05/2023 - 05/2006
7CholesterolIBA
01/2023 - 04/2011
7NF-kappa B (NF-kB)IBA
01/2021 - 05/2007
6ErbB Receptors (EGF Receptor)IBA
03/2024 - 01/2019
6Fibronectins (Fibronectin)IBA
01/2024 - 09/2003
6UbiquitinIBA
12/2023 - 11/2012
6KynurenineIBA
12/2023 - 10/2017
6Biocompatible Materials (Biomaterials)IBA
01/2022 - 01/2017
6Cisplatin (Platino)FDA LinkGeneric
01/2022 - 09/2010
6LipopolysaccharidesIBA
04/2021 - 06/2005
6AntioxidantsIBA
10/2019 - 10/2008
6Insulin (Novolin)FDA Link
12/2018 - 09/2011
5SolutionsIBA
04/2024 - 08/2002
5GlycogenIBA
02/2024 - 01/2020
5Immunoglobulin G (IgG)IBA
01/2024 - 09/2017
5Antiviral Agents (Antivirals)IBA
12/2023 - 05/2016
5CateninsIBA
06/2023 - 01/2017
5Neoplasm Antigens (Tumor Antigens)IBA
01/2023 - 06/2002
5utomilumabIBA
01/2022 - 09/2017
5Imatinib Mesylate (Gleevec)FDA Link
01/2021 - 04/2012
5Atrial Natriuretic Factor (ANF)IBA
01/2019 - 05/2015
5FibrinIBA
01/2018 - 07/2012
5Estrogen ReceptorsIBA
01/2018 - 02/2011
5DNA-Binding Proteins (DNA Binding Protein)IBA
01/2018 - 03/2013
5Interleukin-17 (Interleukin 17)IBA
12/2013 - 08/2008
4Glutathione (Reduced Glutathione)IBA
05/2024 - 06/2012
4PerforinIBA
02/2024 - 01/2019

Therapy/Procedure

64Therapeutics
05/2024 - 06/2005
31Drug Therapy (Chemotherapy)
04/2024 - 01/2003
26Immunotherapy
01/2024 - 03/2007
11Radiotherapy
01/2023 - 02/2011